PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.125
Bid: 17.75
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.75 (4.225%)
Open: 18.125
High: 18.125
Low: 18.125
Prev. Close: 18.125
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Gfinity up on Athlos launch; OptiBiotix slides

Wed, 24th Aug 2022 10:32

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Drumz PLC, up 26% at 0.79 pence, 12-month range 0.45p-0.9p. Extends gains after rising 19% on Tuesday. The software sector investment firm last issued an update in July, when it said investee Surrey-based Acuity Risk Management Ltd reported revenue growth for its financial year ended March 31 with strong growth continuing since.

----------

Gfinity PLC, up 15% at 1.21p, 12-month range 0.75p-5.47p. The e-sports firm reports launch of 100%-owned Athlos Game Technologies. "Athlos provides its clients with a tournament-based platform that leverages the power of competitive gaming to deepen player engagement; to lower player churn; and to increase average revenue per user," it says, adding that work is continuing on development of deeper automation and scale. Says Athlos has a growing number of clients on recurring annual contracts and a strong pipeline of prospective future customers.

----------

AIM - LOSERS

----------

OptiBiotix Health PLC, down 26% at 20.08p, 12-month range 18p-58p. Expects current sales in new structure to be "materially lower" than expected, at around GBP120,000, with sales normalising in the second half but "insufficient" to make up the deficit. Expects return to healthy growth in 2023. "We believe the difference in sales is partly a timing issue with a couple of larger partners delaying restocking due to uncertainty in the economic environment, and Apollo Hospitals and Nahdi Medical postponing launches until H2 as a result of regulatory approvals taking longer than expected," it says.

----------

Rosslyn Data Technologies PLC, down 14% at 2.02p, 12-month range 1.50p-5.98p. Snaps winning streak, after rising 9.5% on Monday and 2.6% on Tuesday. The data management and analytics service provider got off to a good start to the week after winning its first enterprise customer through partnership with indirect procurement service provider Chain IQ Group AG. The initial contract is "of relatively small monetary value" but it expects further contracts to come from partnership.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
28 Feb 2022 14:24

OptiBiotix Health ends year in line with expectations

(Sharecast News) - OptiBiotix Health updated the market on its trading ahead of its final results on Monday, reporting total invoiced sales of £2.2m in 2021 - an increase of 46.7% year-on-year, and in line with market expectations.

Read more
9 Feb 2022 18:13

TRADING UPDATES: Chaarat Gold beats guidance for 2021 Kapan output

TRADING UPDATES: Chaarat Gold beats guidance for 2021 Kapan output

Read more
9 Feb 2022 11:56

OptiBiotix lays out strategy for investment and growth

(Sharecast News) - Life sciences company OptiBiotix Health updated the market on its strategic and commercial progress on Wednesday, reporting that the next phase of its strategy would involve reinvesting proceeds from the recent sale of SkinBioTherapeutics shares, which generated £2m.

Read more
18 Jan 2022 21:27

TRADING UPDATES: Biffa chair responds to shareholders; Kromek improves

TRADING UPDATES: Biffa chair responds to shareholders; Kromek improves

Read more
5 Jan 2022 15:31

OptiBiotix receives British Retail Consortium accreditation

OptiBiotix receives British Retail Consortium accreditation

Read more
15 Dec 2021 22:09

IN BRIEF: OptiBiotix Health signs supply deal in Saudi Arabia

IN BRIEF: OptiBiotix Health signs supply deal in Saudi Arabia

Read more
15 Dec 2021 14:45

OptiBiotix signs supply deal with Saudi Arabia chemist chain

(Sharecast News) - Life sciences company OptiBiotix Health has signed an exclusive supply agreement with pharmacy chain Nahdi Medical, it announced on Wednesday, for the sales of its 'GoFigure' and 'SlimBiome Medical' weight management products in Saudi Arabia.

Read more
9 Dec 2021 15:37

OptiBiotix signs deal with massive chemist chain in India

(Sharecast News) - OptiBiotix Health said on Thursday that its India subsidiary has signed an exclusive sales agreement with one of the leading hospital and pharmacy chains in the country, Apollo Hospitals Enterprises, for the sale of its 'GoFigure' weight management product range in India.

Read more
1 Dec 2021 19:27

TRADING UPDATES: Peel Hunt revenue tanks; Marlowe reaffirms guidance

TRADING UPDATES: Peel Hunt revenue tanks; Marlowe reaffirms guidance

Read more
17 Nov 2021 19:36

TRADING UPDATES: 3i Infrastructure opens USD512 million investment

TRADING UPDATES: 3i Infrastructure opens USD512 million investment

Read more
17 Nov 2021 10:56

OptiBiotix Health forms operating subsidiary in India

(Sharecast News) - Life sciences company OptiBiotix Health announced the formation of its new India subsidiary OptiBiotix Health India (OHI) on Wednesday.

Read more
25 Oct 2021 10:49

IN BRIEF: OptiBiotix Health says SlimBiome approved by Health Canada

IN BRIEF: OptiBiotix Health says SlimBiome approved by Health Canada

Read more
30 Sep 2021 15:45

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

EARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows

Read more
1 Sep 2021 15:46

Director dealings: Optibiotix CEO ups stake

(Sharecast News) - Optibiotix Health revealed on Wednesday that chief executive René Kamminga had purchased 8,188 ordinary shares in the AIM-listed life sciences firm.

Read more
10 Aug 2021 19:24

TRADING UPDATES: Barkby expects revenue growth; Beeks trading in line

TRADING UPDATES: Barkby expects revenue growth; Beeks trading in line

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.